Syndromes of hormone resistance in the hypothalamic-pituitary-thyroid axis

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 20, Issue 4, 2006, Pages 529-546

  Beck Peccoz, Paolo ^a   Persani, Luca ^b   Calebiro, Davide ^b   Bonomi, Marco ^b   Mannavola, Deborah ^a   Campi, Irene ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

deiodinases; MCT8; SECISBP2; thyroid hormones; transporter; TRH; TSH

Indexed keywords

ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DEXTROTHYROXINE; DOPAMINE RECEPTOR STIMULATING AGENT; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; HORMONE; LEVOTHYROXINE; LIOTHYRONINE; MONOCARBOXYLATE TRANSPORTER; PROTIRELIN; SOMATOSTATIN DERIVATIVE; THYROID HORMONE; THYROID HORMONE DERIVATIVE; THYROID HORMONE RECEPTOR; THYROID HORMONE RECEPTOR BETA; THYRONINE; THYROTROPIN; THYROXINE; TIRATRICOL;

CLINICAL FEATURE; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; DRUG BINDING; GENE INACTIVATION; GENE MUTATION; GENETIC CODE; GENETIC COUNSELING; GRAVES DISEASE; HORMONE ACTION; HORMONE RESISTANCE; HORMONE SUBSTITUTION; HUMAN; HYPOPARATHYROIDISM; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; MISSENSE MUTATION; PATHOPHYSIOLOGY; PSEUDOHYPOPARATHYROIDISM; RARE DISEASE; REVIEW; SECOND MESSENGER; TACHYCARDIA; THYROID HORMONE METABOLISM; THYROID HORMONE RESISTANCE; THYROTOXICOSIS; THYROTROPIN RELEASE;

AMINO ACID SEQUENCE; CHILD; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHYROIDISM; MALE; MONOCARBOXYLIC ACID TRANSPORTERS; MUTATION; RECEPTORS, THYROTROPIN; RECEPTORS, THYROTROPIN-RELEASING HORMONE; RNA-BINDING PROTEINS; THYROID GLAND; THYROID HORMONE RECEPTORS BETA; THYROID HORMONE RESISTANCE SYNDROME; THYROTROPIN;

EID: 33845271250     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2006.11.001     Document Type: Review

References (64)

1. Collu R., Tang J., Castagnè J., et al. A novel mechanism for isolated central hypothyroidism: inactivating mutations in the thyrotropin-releasing hormone receptor gene. The Journal of Clinical Endocrinology and Metabolism 82 (1997) 1361-1365
2. Bonomi M., Proverbio M.C., Weber G., et al. Hyperplastic pituitary gland, high serum glycoprotein hormone α-subunit, and variable circulating thyrotropin (TSH) levels as hallmark of central hypothyroidism due to mutations of the TSHβ gene. The Journal of Clinical Endocrinology and Metabolism 86 (2001) 1600-1604
3. Persani L., Ferretti E., Borgato S., et al. Circulating TSH bioactivity in sporadic central hypothyroidism. The Journal of Clinical Endocrinology and Metabolism 85 (2000) 3631-3635
4. Ferretti E., Persani L., Jaffrain-Rea M.L., et al. Evaluation of the adequacy of l-T4 replacement therapy in patients with central hypothyroidism. The Journal of Clinical Endocrinology and Metabolism 84 (1999) 924-929
5. Shimon I., Cohen O., Lubetsky A., et al. Thyrotropin suppression by thyroid hormone replacement is correlated with thyroxine level normalization in central hypothyroidism. Thyroid 12 (2002) 823-827
6. Stanbury J.B., Rocmans P., Buhler U.K., et al. Congenital hypothyroidism with impaired thyroid response to thyrotropin. The New England Journal of Medicine 21 (1968) 1132-1136
7. Sunthornthepvarakul T., Gottschalk M.E., Hayashi Y., et al. Resistance to thyrotropin caused by mutations in the thyrotropin-receptor gene. The New England Journal of Medicine 332 (1995) 155-160
8. de Roux N., Misrahi M., Brauner R., et al. Four families with loss of function mutations of the thyrotropin receptor. The Journal of Clinical Endocrinology and Metabolism 81 (1996) 4229-4235
9. Clifton-Bligh R.J., Gregory J.W., Ludgate M., et al. Two novel mutations in the thyrotropin (TSH) receptor gene in a child with resistance to TSH. The Journal of Clinical Endocrinology and Metabolism 82 (1997) 1094-1100
10. Abramowicz M.J., Duprez L., Parma J., et al. Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland. The Journal of Clinical Investigation 99 (1997) 3018-3024
11. Biebermann H., Schöneberg T., Krude H., et al. Mutations of the human thyrotropin receptor gene causing thyroid hypoplasia and persistent congenital hypothyroidism. The Journal of Clinical Endocrinology and Metabolism 82 (1997) 3471-3480
12. Gagné N., Parma J., Deal C., et al. Apparent congenital athyreosis contrasting with normal plasma thyroglobulin levels and associated with inactivating mutations in the thyrotropin receptor gene: are athyreosis and ectopic thyroid distinct entities?. The Journal of Clinical Endocrinology and Metabolism 83 (1998) 1771-1775
13. Tiosano D., Pannain S., Vassart G., et al. The hypothyroidism in an inbred kindred with congenital thyroid hormone and glucocorticoid deficiency is due to a mutation producing a truncated thyrotropin receptor. Thyroid 9 (1999) 887-894
14. Tonacchera M., Agretti P., Pinchera A., et al. Congenital hypothyroidism with impaired thyroid response to thyrotropin (TSH) and absent circulating thyroglobulin: evidence for a new inactivating mutation of the TSH receptor gene. The Journal of Clinical Endocrinology and Metabolism 85 (2000) 1001-1008
15. Russo D., Betterle C., Arturi F., et al. A novel mutation in the thyrotropin (TSH) receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistance to TSH. The Journal of Clinical Endocrinology and Metabolism 85 (2000) 4238-4242
16. Nagashima T., Murakami M., Onigata K., et al. Novel inactivating missense mutations in the thyrotropin receptor gene in Japanese children with resistance to thyrotropin. Thyroid 11 (2001) 551-559
17. Tonacchera M., Agretti P., De Marco G., et al. Thyroid resistance to TSH complicated by autoimmune thyroiditis. The Journal of Clinical Endocrinology and Metabolism 86 (2001) 4543-4546
18. Bretones P., Duprez L., Parma J., et al. A familial case of congenital hypothyroidism caused by a homozygous mutation of the thyrotropin receptor gene. Thyroid 11 (2001) 977-980
19. Alberti L., Proverbio M.C., Costagliola S., et al. Germline mutations of TSH receptor gene as cause of nonautoimmune subclinical hypothyroidism. The Journal of Clinical Endocrinology and Metabolism 87 (2002) 2549-2555
20. Calaciura F., Motta R.M., Miscio G., et al. Subclinical hypothyroidism in early childhood: a frequent outcome of transient neonatal hyperthyrotropinemia. The Journal of Clinical Endocrinology and Metabolism 87 (2002) 3209-3214
21. Jordan N., Williams N., Gregory J.W., et al. The W546X mutation of the thyrotropin receptor gene: potential major contributor to thyroid dysfunction in a Caucasian population. The Journal of Clinical Endocrinology and Metabolism 88 (2003) 1002-1003
22. Park S.M., Clifton-Bligh R.J., Betts P., et al. Congenital hypothyroidism and apparent athyreosis with compound heterozygosity or compensated hypothyroidism with probable hemizygosity for inactivating mutations of the TSH receptor. Clinical Endocrinology 60 (2004) 220-227
23. Tonacchera M., Perri A., De Marco G., et al. Low prevalence of thyrotropin receptor mutations in a large series of subjects with sporadic and familial nonautoimmune subclinical hypothyroidism. The Journal of Clinical Endocrinology and Metabolism 89 (2004) 5787-5793
24. Richter-Unruh A., Hauffa B.P., Pfarr N., et al. Congenital primary hypothyroidism in a Turkish family caused by a homozygous nonsense mutation (R609X) in the thyrotropin receptor gene. Thyroid 14 (2004) 971-974
25. Camilot M., Teofoli F., Gandini A., et al. Thyrotropin receptor gene mutations and TSH resistance: variable expressivity in the heterozygous. Clinical Endocrinology 63 (2005) 146-151
26. Fricke-Otto S., Pfarr N., Muhlenberg R., et al. Mild congenital primary hypothyroidism in a Turkish family caused by a homozygous missense thyrotropin receptor (TSHR) gene mutation (A593V). Experimental and Clinical Endocrinology & Diabetes 113 (2005) 582-585
27. Tsunekawa K., Onigata K., Morimura T., et al. Identification and functional analysis of novel inactivating thyrotropin receptor mutations in patients with thyrotropin resistance. Thyroid 16 (2006) 471-479
28. Refetoff S. Resistance to thyrotropin. Journal of Endocrinological Investigation 26 (2003) 770-779
29. Calebiro D., de Filippis T., Lucchi S., et al. Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance. Human Molecular Genetics 14 (2005) 2991-3002
30. Xie J., Pannain S., Pohlenz J., et al. Resistance to thyrotropin (TSH) in three families is not associated with mutations in the TSH receptor or TSH. The Journal of Clinical Endocrinology and Metabolism 82 (1997) 3933-3940
31. Nogueira C.R., Nguyen L.Q., Coelho-Neto J.R., et al. Structural analysis of the thyrotropin receptor in four patients with congenital hypothyroidism due to thyroid hypoplasia. Thyroid 9 (1999) 523-529
32. Grasberger H., Vaxillaire M., Pannain S., et al. Identification of a locus for nongoitrous congenital hypothyroidism on chromosome 15q25.3-26.1. Human Genetics 7 (2005) 1-8
33. Mantovani G., Ballarè E., Giammona E., et al. The Gsalpha gene: predominant maternal origin of transcription in human thyroid gland and gonads. The Journal of Clinical Endocrinology and Metabolism 87 (2002) 4736-4740
34. Kopp P. Perspective: genetic defects in the etiology of congenital hypothyroidism. Endocrinology 143 (2002) 2019-2024
35. Vigone M.C., Fugazzola L., Zamproni I., et al. persistent mild hypothyroidism associated with novel sequence variants of the DUOX2 gene in two siblings. Human Mutation 26 (2005) 395
36. Usala S.J., Bale A.E., Gesundheit N., et al. Tight linkage between the syndrome of generalized thyroid hormone resistance and the human c-erbAβ gene. Molecular endocrinology (Baltimore, Md.) 2 (1988) 1217-1220
37. Refetoff S., Weiss R., and Usala S. The syndromes of resistance to thyroid hormone. Endocrine Reviews 14 (1993) 348-399
38. Jameson J. Mechanism by which thyroid hormone receptor mutations cause clinical syndromes of resistance to thyroid hormone. Thyroid 4 (1994) 485-492
39. Brucker-Davis F., Scarulis M.C., Grace M.B., et al. Genetic and clinical features in 42 kindreds with resistance to thyroid hormone. Annals of Internal Medicine 123 (1995) 572-583
40. Adams M., Matthews C., Collingwood T.N., et al. Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the hormone receptor β gene. The Journal of Clinical Investigation 94 (1994) 506-515
41. Beck-Peccoz P., and Chatterjee V.K.K. The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 4 (1994) 225-232
42. Dumitrescu A.M., Liao X.H., Best T.B., et al. A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. American Journal of Human Genetics 74 (2004) 168-175
43. Friesema E.C., Grueters A., Biebermann H., et al. Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 364 (2004) 1435-1437
44. Brockmann K., Dumitrescu A.M., Best T.T., et al. X-linked paroxysmal dyskinesia and severe global retardation caused by defective MCT8 gene. Journal of Neurology 252 (2005) 663-666
45. Schwartz C.E., May M.M., Carpenter N.J., et al. Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene. American Journal of Human Genetics 77 (2005) 41-53
46. Maranduba C.M., Friesema E.C., Kok F., et al. Decreased cellular uptake and metabolism in Allan-Herndon-Dudley syndrome (AHDS) due to a novel mutation in the MCT8 thyroid hormone transporter. Journal of Medical Genetics 43 (2006) 457-460
47. Biebermann H., Ambrugger P., Tarnow P., et al. Extended clinical phenotype, endocrine investigations and functional studies of a loss-of-function mutation A150V in the thyroid hormone specific transporter MCT8. European Journal of Endocrinology 153 (2005) 359-366
48. Holden K.R., Zuniga O.F., May M.M., et al. X-linked MCT8 gene mutations: characterization of the pediatric neurologic phenotype. Journal of Child Neurology 20 (2005) 852-857
49. Herzovich V., Vaiani E., Marino R., et al. Unexpected peripheral markers of thyroid function in a patient with a novel mutation of the MCT8 thyroid hormone transporter gene. Hormone Research 67 (2006) 1-6
50. Dumitrescu A.M., Liao X.H., Abdullah M.S., et al. Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nature Genetics 37 (2005) 1247-1252
51. Berry M.J. Insights into the hierarchy of selenium incorporation. Nature Genetics 37 (2005) 1162-1163
52. Gurnell M., Beck-Peccoz P., and Chatterjee V.K.K. Resistance to thyroid hormone. In: DeGroot L.J., and Jameson J.L. (Eds). Endocrinology. 5th edn. (2006), Elsevier Saunders, Philadelphia 2227-2237
53. Takeda K., Sakurai A., DeGroot L.J., et al. Recessive inheritance of thyroid hormone resistance caused by complete deletion of the protein-coding region of the thyroid hormone receptor-β gene. The Journal of Clinical Endocrinology and Metabolism 74 (1992) 49-55
54. Yen P.M., and Chin W.W. Molecular mechanism of dominant negative activity by nuclear hormone receptors. Molecular endocrinology (Baltimore, Md.) 8 (1994) 1450-1454
55. Weiss R.E., Xu J., Ning G., et al. Mice deficient in the steroid receptor co-activator 1 (SRC-1) are resistant to thyroid hormone. EMBO Journal 18 (1999) 1900-1904
56. Friesema E.C., Ganguly S., Abdalla A., et al. Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. The Journal of Biological Chemistry 278 (2003) 40128-40135
57. Schneider M.J., Fiering S.N., Pallud, et al. Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. Molecular endocrinology (Baltimore, Md.) 15 (2001) 2137-2148
58. Beck-Peccoz P., and Mannavola D. Syndromes of resistance to thyroid hormone: clinical aspects. In: Beck-Peccoz P. (Ed). Syndromes of Hormone Resistance on the Hypothalamic-Pituitary-Thyroid Axis (2004), Kluwer Academic Publishers, Boston 69-88
59. Geffner M.E., Su F., Ross N.S., et al. An argine to histidine mutation in codon 311of the c-erbA β gene results in a mutant thyroid hormone receptor that does not mediate a dominant negative phenotype. The Journal of Clinical Investigation 91 (1993) 538-546
60. Beck-Peccoz P., Brucker-Davis F., Persani L., et al. Thyrotropin-secreting pituitary tumors. Endocrine Reviews 17 (1996) 610-638
61. Beck-Peccoz P., Piscitelli G., Cattaneo M., et al. Successful treatment of hyperthyroidism due to nonneoplastic pituitary TSH hypersecretion with 3, 5,3′-triiodothyroacetic acid (TRIAC). Journal of Endocrinological Investigation 6 (1983) 217-223
62. Hamon P., Bovier-Lapierre M., Robert M., et al. Hyperthyroidism due to selective pituitary resistance to thyroid hormones in a 15-month-old boy: efficacy of D-Thyroxine therapy. The Journal of Clinical Endocrinology and Metabolism 67 (1988) 1089-1093
63. Crinò A., Borrelli P., Salvatori R., et al. Anti-iodothyronine autoantibodies in a girl with hyperthyroidism due to pituitary resistance to thyroid hormones. Journal of Endocrinological Investigation 15 (1992) 113-120
64. Takeda T., Suzuki S., Liu R.T., et al. Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone. The Journal of Clinical Endocrinology and Metabolism 80 (1995) 2033-2040